Name: Consumer Genetic Technologies: Ethical and Legal Considerations (en Inglés)
Price: 482647.00 COP
Availability: InStock
Author: Cohen, I. Glenn ; Farahany, Nita A. ; Greely, Henry T.
ISBN: 9781108836616

portada Consumer Genetic Technologies: Ethical and Legal Considerations (en Inglés)

Formato

Libro Físico

Ilustrado por

I. Glenn Cohen

Nita A. Farahany

Henry T. Greely

Editorial

Cambridge University Press

Autor

Cohen, I. Glenn ; Farahany, Nita A. ; Greely, Henry T.

Año

2021

Idioma

Inglés

N° páginas

302

Encuadernación

Tapa Dura

Dimensiones

22.9 x 15.2 x 1.8 cm

Peso

0.57 kg.

ISBN13

9781108836616

Categorías

Derecho médico sanitario

Consumer Genetic Technologies: Ethical and Legal Considerations (en Inglés)

I. Glenn Cohen (Ilustrado por) · Nita A. Farahany (Ilustrado por) · Henry T. Greely (Ilustrado por) · Cambridge University Press · Tapa Dura

Libro Nuevo

$ 482.647

$ 965.293

Ahorras: $ 482.647

50% descuento

Envío normal

Origen: España (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 27 de Mayo y el Jueves 06 de Junio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Consumer Genetic Technologies: Ethical and Legal Considerations (en Inglés)"

For the average person, genetic testing has two very different faces. The rise of genetic testing is often promoted as the democratization of genetics by enabling individuals to gain insights into their unique makeup. At the same time, many have raised concerns that genetic testing and sequencing reveal intensely personal and private information. As these technologies become increasingly available as consumer products, the ethical, legal, and regulatory challenges presented by genomics are ever looming. Assembling multidisciplinary experts, this volume evaluates the different models used to deliver consumer genetics and considers a number of key questions: How should we mediate privacy and other ethical concerns around genetic databases? Does aggregating data from genetic testing turn people into products by commercializing their data? How might this data reduce or exacerbate existing healthcare disparities? Contributing authors also provide guidance on protecting consumer privacy and safety while promoting innovation.